Cataract News and Research

Latest Cataract News and Research

Exudation-free period key to cataract surgery success in AMD

Cataract surgery can benefit patients with exudative age-related macular degeneration previously treated with anti-vascular endothelial growth factors if they have been treated and are exudation-free for more than 12 months, study findings indicate.

11 Dec 2014

Welch Allyn, LKC Technologies sign distribution agreement for RETeval DR screening device

Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and LKC Technologies, Inc., the worldwide leader in visual electrophysiology and inventor of the RETeval DR diabetic retinopathy assessment device announced an exclusive distribution agreement.

4 Dec 2014

Study explores association between statin use and cataracts

Few classes of drugs have had such a transformative effect on the prevention of cardiovascular disease (CVD) as have statins, prescribed to reduce total cholesterol and low-density lipoprotein cholesterol.

4 Dec 2014

DEX implant improves visual acuity in patients with diabetic macular oedema

Patients with diabetic macular oedema benefit from intravitreal dexamethasone implants, a study shows, with the treatment improving best-corrected visual acuity with an acceptable safety profile.

1 Dec 2014

Eylea receives Health Canada approval for treatment of CRVO and DME

Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

1 Dec 2014

Massachusetts Eye and Ear offers femtosecond laser technology to Boston-area patients

Patients choosing cataract surgery at Massachusetts Eye and Ear may now elect to have laser-assisted cataract surgery with the femtosecond LensSx® Laser. The hospital is one of the few in New England to offer the advanced technology, which enables surgeons to more precisely perform cataract surgery aided by a computer-controlled laser.

14 Nov 2014

Eye screenings of underserved populations reveal one in five has early stage diabetic retinopathy

Eye screenings of people with diabetes in underserved communities revealed that one in five had early stage diabetic retinopathy, according to a new study by a research consortium including investigators at the University of Alabama at Birmingham.

13 Nov 2014

Leading causes of blindness can be detected by looking at how eyes respond to watching TV

One of the leading causes of blindness worldwide could be detected by how our eyes respond to watching TV according to a new study from researchers at City University London.

11 Nov 2014

Omeros provides update on OMS824 for treatment of schizophrenia, Huntington's disease

Omeros Corporation today provided an update on OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor in development for the treatment of schizophrenia and Huntington's disease.

21 Oct 2014

VisionCare's Implantable Miniature Telescope gets FDA approval for treating end-stage AMD

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration approved the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration who are age 65 or older.

14 Oct 2014

Eye Co receives patent for new class of eye disease drugs

Australian ocular technology company Eye Co Pty Ltd has achieved a key commercial milestone, with a patent granted protecting its new class of eye disease drugs throughout the high value European market.

14 Oct 2014

Sightsavers launches biggest ever appeal to raise funds for sight-restoring surgeries

A blind man's sight-restoring operation was broadcast live around the world at 1.30pm (BST) today from a hospital in Malawi.

8 Oct 2014

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

30 Sep 2014

Escalon Medical announces operating results for fiscal 2014; VuPad receives CE mark authorization

Escalon Medical Corp. (NASDAQ: ESMC) today announced its operating results for the fiscal year ended September 30, 2014.

27 Sep 2014

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

27 Sep 2014

EYLEA Injection gets approval in Japan for treatment of myopic CNV

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare for EYLEA (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV).

22 Sep 2014

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

16 Sep 2014

Cataract News and Research

Latest Cataract News and Research

Exudation-free period key to cataract surgery success in AMD

Welch Allyn, LKC Technologies sign distribution agreement for RETeval DR screening device

Study explores association between statin use and cataracts

DEX implant improves visual acuity in patients with diabetic macular oedema

Eylea receives Health Canada approval for treatment of CRVO and DME

Massachusetts Eye and Ear offers femtosecond laser technology to Boston-area patients

Eye screenings of underserved populations reveal one in five has early stage diabetic retinopathy

Leading causes of blindness can be detected by looking at how eyes respond to watching TV

Omeros provides update on OMS824 for treatment of schizophrenia, Huntington's disease

VisionCare's Implantable Miniature Telescope gets FDA approval for treating end-stage AMD

Eye Co receives patent for new class of eye disease drugs

Sightsavers launches biggest ever appeal to raise funds for sight-restoring surgeries

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Escalon Medical announces operating results for fiscal 2014; VuPad receives CE mark authorization

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

EYLEA Injection gets approval in Japan for treatment of myopic CNV

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Japanese surgeons first to implant InnFocus MicroShunt

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cataract News and Research

Latest Cataract News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in